Strong R&D commitment to developing therapeutics against SARS-CoV-2 virus Overall R&D investment up 7% to 3.7 billion EUR in 2020 (18.9% of net sales) Outlook 2021: slight year-on-year increase in net sales on a comparable basis Boehringer Ingelheim stepped up its investments in R&D significantly in 2020 in pursuit of innovative medicines and therapies for diseases for which no satisfactory trea..
원문링크 : Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19
![[동물극장 단짝] 칠둥이네, 사랑하면 알게 되는](http://img1.daumcdn.net/thumb/R800x0/?scode=mtistory2&fname=https%3A%2F%2Fblog.kakaocdn.net%2Fdn%2FSinsD%2FbtrskuHWibx%2Fzenogm5j6GltwtNthbpN1K%2Fimg.jpg "[동물극장 단짝] 칠둥이네, 사랑하면 알게 되는")
네이버 블로그
티스토리
커뮤니티